newsfilter
← Latest News
GlobeNewswire·

LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Entered into agreement with Bristol Myers Squibb for mavacamten in China and other Asian marketsPhase 3 data from EXPLORER-CN trial of mavacamten presented in an oral late-breaking science session at the European Society